362 related articles for article (PubMed ID: 12620735)
61. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe.
Hansson L; Lloyd A; Anderson P; Kopp Z
Blood Press; 2002; 11(1):35-45. PubMed ID: 11926349
[TBL] [Abstract][Full Text] [Related]
62. Cost and health consequences of reducing the population intake of salt.
Selmer RM; Kristiansen IS; Haglerod A; Graff-Iversen S; Larsen HK; Meyer HE; Bonaa KH; Thelle DS
J Epidemiol Community Health; 2000 Sep; 54(9):697-702. PubMed ID: 10942450
[TBL] [Abstract][Full Text] [Related]
63. Global burden of cardiovascular disease and stroke: hypertension at the core.
Lackland DT; Weber MA
Can J Cardiol; 2015 May; 31(5):569-71. PubMed ID: 25795106
[No Abstract] [Full Text] [Related]
64. Promoting cardiovascular health worldwide: strategies, challenges, and opportunities.
Castellano JM; Narula J; Castillo J; Fuster V
Rev Esp Cardiol (Engl Ed); 2014 Sep; 67(9):724-30. PubMed ID: 25172068
[TBL] [Abstract][Full Text] [Related]
65. Generalizability of cost-utility analyses across countries and settings.
Ginsberg GM
Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):845-52. PubMed ID: 24182605
[TBL] [Abstract][Full Text] [Related]
66. The Socioeconomic Effects of Uncontrolled Hypertension.
Athanasakis K
Curr Vasc Pharmacol; 2017; 16(1):5-9. PubMed ID: 28412912
[TBL] [Abstract][Full Text] [Related]
67. Blood pressure and the global burden of cardiovascular disease.
Rodgers A; MacMahon S
Clin Exp Hypertens; 1999; 21(5-6):543-52. PubMed ID: 10423080
[TBL] [Abstract][Full Text] [Related]
68. Which interventions offer best value for money in primary prevention of cardiovascular disease?
Cobiac LJ; Magnus A; Lim S; Barendregt JJ; Carter R; Vos T
PLoS One; 2012; 7(7):e41842. PubMed ID: 22844529
[TBL] [Abstract][Full Text] [Related]
69. The cost of hypertension-related ill-health attributable to environmental noise.
Harding AH; Frost GA; Tan E; Tsuchiya A; Mason HM
Noise Health; 2013; 15(67):437-45. PubMed ID: 24231422
[TBL] [Abstract][Full Text] [Related]
70. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina.
Konfino J; Mekonnen TA; Coxson PG; Ferrante D; Bibbins-Domingo K
PLoS One; 2013; 8(9):e73824. PubMed ID: 24040085
[TBL] [Abstract][Full Text] [Related]
71. The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data.
McAloon CJ; Boylan LM; Hamborg T; Stallard N; Osman F; Lim PB; Hayat SA
Int J Cardiol; 2016 Dec; 224():256-264. PubMed ID: 27664572
[TBL] [Abstract][Full Text] [Related]
72. The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality.
Yosefy C; Dicker D; Viskoper JR; Tulchinsky TH; Ginsberg GM; Leibovitz E; Gavish D
Prev Med; 2003 Dec; 37(6 Pt 1):571-6. PubMed ID: 14636790
[TBL] [Abstract][Full Text] [Related]
73. CardioPulse: Prevention of global cardiovascular disease.
Yusuf S; Wood D; Ralston J; Reddy KS
Eur Heart J; 2016 Feb; 37(6):505-7. PubMed ID: 27458620
[No Abstract] [Full Text] [Related]
74. Knowledge and attitudes towards hypertension and hypercholesterolemia in a population of southern Germany: results from a population survey in the Augsburg area.
Weiland SK; Keil U; Spelsberg A
Soz Praventivmed; 1991; 36(1):5-8. PubMed ID: 2053425
[TBL] [Abstract][Full Text] [Related]
75. DALYs and QALYs in developing countries.
Zarate V
Health Aff (Millwood); 2007; 26(4):1197-8. PubMed ID: 17630466
[No Abstract] [Full Text] [Related]
76. DEALE-ing and discounting: a simple way to compute the accrued costs of preventive strategies.
Durand-Zaleski I; Zaleski S
Med Decis Making; 1994; 14(1):98-103. PubMed ID: 8152363
[TBL] [Abstract][Full Text] [Related]
77. Disease management and pharmacoeconomics as tools for mass prevention of hypertensive complications.
Goldberg Arnold RJ
Heart Dis; 2001; 3(3):152-6. PubMed ID: 11975786
[TBL] [Abstract][Full Text] [Related]
78. Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.
Ndindjock R; Gedeon J; Mendis S; Paccaud F; Bovet P
Bull World Health Organ; 2011 Apr; 89(4):286-95. PubMed ID: 21479093
[TBL] [Abstract][Full Text] [Related]
79. Worldwide epidemic of hypertension.
Chockalingam A; Campbell NR; Fodor JG
Can J Cardiol; 2006 May; 22(7):553-5. PubMed ID: 16755308
[TBL] [Abstract][Full Text] [Related]
80. The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles.
Liu Y; Dalal K; Stollenwerk B
PLoS One; 2013; 8(4):e61718. PubMed ID: 23637891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
